Hey bHLH transcription factors

Current Topics in Developmental Biology

Volumn 110, Issue , 2014, Pages 285-315

  Weber, David ^a   Wiese, Cornelia ^a   Gessler, Manfred ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Angiogenesis; Brugada syndrome; Cardiac hypertrophy; CoupTF II; E box; Heart development; Hey genes; Histone deacetylase; Neurogenesis; Notch signaling; Stem cell maintenance; Ventricular septum defect

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL CYCLE PROTEIN; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; HEY1 PROTEIN, HUMAN; HEY2 PROTEIN, HUMAN; NCOA2 PROTEIN, HUMAN; NOTCH RECEPTOR; NR2F2 PROTEIN, HUMAN; NUCLEAR RECEPTOR COACTIVATOR 2; REPRESSOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; HEART DISEASE; HUMAN; INJURIES; KNOCKOUT MOUSE; METABOLISM; MUSCLE DEVELOPMENT; NEOPLASM; PATHOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARDIOVASCULAR SYSTEM; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; COUP TRANSCRIPTION FACTOR II; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEART DISEASES; HUMANS; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE, SMOOTH, VASCULAR; NEOPLASMS; NUCLEAR RECEPTOR COACTIVATOR 2; RECEPTORS, NOTCH; REPRESSOR PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84907707760     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-405943-6.00008-7     Document Type: Chapter

References (132)

1. Aranguren X.L., Agirre X., Beerens M., Coppiello G., Uriz M., Vandersmissen I., et al. Unraveling a novel transcription factor code determining the human arterial-specific endothelial cell signature. Blood 2013, 122:3982-3992.
2. Aranguren X.L., Beerens M., Coppiello G., Wiese C., Vandersmissen I., Lo Nigro A., et al. COUP-TFII orchestrates venous and lymphatic endothelial identity by homo- or hetero-dimerisation with PROX1. Journal of Cell Science 2013, 126:1164-1175.
3. Belandia B., Powell S.M., Garcia-Pedrero J.M., Walker M.M., Bevan C.L., Parker M.G. Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Molecular and Cellular Biology 2005, 25:1425-1436.
4. Belyea B.C., Naini S., Bentley R.C., Linardic C.M. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis. Clinical Cancer Research 2011, 17:7324-7336.
5. Bezzina C.R., Barc J., Mizusawa Y., Remme C.A., Gourraud J.B., Simonet F., et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nature Genetics 2013, 45:1044-1049.
6. Blokzijl A., Dahlqvist C., Reissmann E., Falk A., Moliner A., Lendahl U., et al. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. Journal of Cell Biology 2003, 163:723-728.
7. Buas M.F., Kabak S., Kadesch T. The Notch effector Hey1 associates with myogenic target genes to repress myogenesis. Journal of Biological Chemistry 2010, 285:1249-1258.
8. Candy P.A., Phillips M.R., Redfern A.D., Colley S.M., Davidson J.A., Stuart L.M., et al. Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients. British Journal of Cancer 2013, 109:1023-1030.
9. Caolo V., Schulten H.M., Zhuang Z.W., Murakami M., Wagenaar A., Verbruggen S., et al. Soluble Jagged-1 inhibits neointima formation by attenuating Notch-Herp2 signaling. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:1059-1065.
10. Chen X., Qin J., Cheng C.M., Tsai M.J., Tsai S.Y. COUP-TFII is a major regulator of cell cycle and Notch signaling pathways. Molecular Endocrinology 2012, 26:1268-1277.
11. Chi J.T., Chang H.Y., Haraldsen G., Jahnsen F.L., Troyanskaya O.G., Chang D.S., et al. Endothelial cell diversity revealed by global expression profiling. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:10623-10628.
12. Chin M.T., Maemura K., Fukumoto S., Jain M.K., Layne M.D., Watanabe M., et al. Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system. Journal of Biological Chemistry 2000, 275:6381-6387.
13. Chun C.Z., Remadevi I., Schupp M.O., Samant G.V., Pramanik K., Wilkinson G.A., et al. Fli+etsrp+hemato-vascular progenitor cells proliferate at the lateral plate mesoderm during vasculogenesis in zebrafish. PloS One 2011, 6:e14732.
14. Coulpier F., Le Crom S., Maro G.S., Manent J., Giovannini M., Maciorowski Z., et al. Novel features of boundary cap cells revealed by the analysis of newly identified molecular markers. Glia 2009, 57:1450-1457.
15. Dahlqvist C., Blokzijl A., Chapman G., Falk A., Dannaeus K., Ibanez C.F., et al. Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development (Cambridge, England) 2003, 130:6089-6099.
16. de Jong D.S., Steegenga W.T., Hendriks J.M., van Zoelen E.J., Olijve W., Dechering K.J. Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells. Biochemical and Biophysical Research Communications 2004, 320:100-107.
17. de Jong D.S., Vaes B.L., Dechering K.J., Feijen A., Hendriks J.M., Wehrens R., et al. Identification of novel regulators associated with early-phase osteoblast differentiation. Journal of Bone and Mineral Research 2004, 19:947-958.
18. Diez H., Fischer A., Winkler A., Hu C.J., Hatzopoulos A.K., Breier G., et al. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Experimental Cell Research 2007, 313:1-9.
19. Doetzlhofer A., Basch M.L., Ohyama T., Gessler M., Groves A.K., Segil N. Hey2 regulation by FGF provides a Notch-independent mechanism for maintaining pillar cell fate in the organ of Corti. Developmental Cell 2009, 16:58-69.
20. Doi H., Iso T., Shiba Y., Sato H., Yamazaki M., Oyama Y., et al. Notch signaling regulates the differentiation of bone marrow-derived cells into smooth muscle-like cells during arterial lesion formation. Biochemical and Biophysical Research Communications 2009, 381:654-659.
21. Doi H., Iso T., Yamazaki M., Akiyama H., Kanai H., Sato H., et al. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 25:2328-2334.
22. Donovan J., Kordylewska A., Jan Y.N., Utset M.F. Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Current Biology 2002, 12:1605-1610.
23. Elagib K.E., Xiao M., Hussaini I.M., Delehanty L.L., Palmer L.A., Racke F.K., et al. Jun blockade of erythropoiesis: Role for repression of GATA-1 by HERP2. Molecular and Cellular Biology 2004, 24:7779-7794.
24. Firulli B.A., Hadzic D.B., McDaid J.R., Firulli A.B. The basic helix-loop-helix transcription factors dHAND and eHAND exhibit dimerization characteristics that suggest complex regulation of function. Journal of Biological Chemistry 2000, 275:33567-33573.
25. Fischer A., Gessler M. Delta-Notch-And then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Research 2007, 35:4583-4596.
26. Fischer A., Klamt B., Schumacher N., Glaeser C., Hansmann I., Fenge H., et al. Phenotypic variability in Hey2 -/-mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome. Mammalian Genome 2004, 15:711-716.
27. Fischer A., Klattig J., Kneitz B., Diez H., Maier M., Holtmann B., et al. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts. Molecular and Cellular Biology 2005, 25:8960-8970.
28. Fischer A., Schumacher N., Maier M., Sendtner M., Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes & Development 2004, 18:901-911.
29. Fischer A., Steidl C., Wagner T.U., Lang E., Jakob P.M., Friedl P., et al. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circulation Research 2007, 100:856-863.
30. Fu M., Rao M., Wang C., Sakamaki T., Wang J., Di Vizio D., et al. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Molecular and Cellular Biology 2003, 23:8563-8575.
31. Fujitani M., Cancino G.I., Dugani C.B., Weaver I.C., Gauthier-Fisher A., Paquin A., et al. TAp73 acts via the bHLH Hey2 to promote long-term maintenance of neural precursors. Current Biology 2010, 20:2058-2065.
32. Fukada S., Yamaguchi M., Kokubo H., Ogawa R., Uezumi A., Yoneda T., et al. Hesr1 and Hesr3 are essential to generate undifferentiated quiescent satellite cells and to maintain satellite cell numbers. Development 2011, 138:4609-4619.
33. Fuke S., Minami N., Kokubo H., Yoshikawa A., Yasumatsu H., Sasagawa N., et al. Hesr1 knockout mice exhibit behavioral alterations through the dopaminergic nervous system. Journal of Neuroscience Research 2006, 84:1555-1563.
34. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437:270-274.
35. -/- mice. Current Biology 2002, 12:1601-1604.
36. Ghosh B., Leach S.D. Interactions between hairy/enhancer of split-related proteins and the pancreatic transcription factor Ptf1-p48 modulate function of the PTF1 transcriptional complex. Biochemical Journal 2006, 393:679-685.
37. Gould F., Harrison S.M., Hewitt E.W., Whitehouse A. Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway. Journal of Virology 2009, 83:6727-6738.
38. Gray C., Packham I.M., Wurmser F., Eastley N.C., Hellewell P.G., Ingham P.W., et al. Ischemia is not required for arteriogenesis in zebrafish embryos. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:2135-2141.
39. Hayakawa F., Towatari M., Ozawa Y., Tomita A., Privalsky M.L., Saito H. Functional regulation of GATA-2 by acetylation. Journal of Leukocyte Biology 2004, 75:529-540.
40. Hayashi H., Kume T. Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PloS One 2008, 3:e2401.
41. Heisig J., Weber D., Englberger E., Winkler A., Kneitz S., Sung W.K., et al. Target gene analysis by microarrays and chromatin immunoprecipitation identifies HEY proteins as highly redundant bHLH repressors. PLoS Genetics 2012, 8:e1002728.
42. Henderson A.M., Wang S.J., Taylor A.C., Aitkenhead M., Hughes C.C. The basic helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation. Journal of Biological Chemistry 2001, 276:6169-6176.
43. Hu X., Chung A.Y., Wu I., Foldi J., Chen J., Ji J.D., et al. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Immunity 2008, 29:691-703.
44. Hulleman E., Quarto M., Vernell R., Masserdotti G., Colli E., Kros J.M., et al. A role for the transcription factor HEY1 in glioblastoma. Journal of Cellular and Molecular Medicine 2009, 13:136-146.
45. Iso T., Chung G., Hamamori Y., Kedes L. HERP1 is a cell type-specific primary target of Notch. Journal of Biological Chemistry 2002, 277:6598-6607.
46. Iso T., Maeno T., Oike Y., Yamazaki M., Doi H., Arai M., et al. Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells. Biochemical and Biophysical Research Communications 2006, 341:708-714.
47. Iso T., Sartorelli V., Chung G., Shichinohe T., Kedes L., Hamamori Y. HERP, a new primary target of Notch regulated by ligand binding. Molecular and Cellular Biology 2001, 21:6071-6079.
48. Iso T., Sartorelli V., Poizat C., Iezzi S., Wu H.Y., Chung G., et al. HERP, a novel heterodimer partner of HES/E(spl) in Notch signaling. Molecular and Cellular Biology 2001, 21:6080-6089.
49. Itoh F., Itoh S., Goumans M.J., Valdimarsdottir G., Iso T., Dotto G.P., et al. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO Journal 2004, 23:541-551.
50. Jalali A., Bassuk A.G., Kan L., Israsena N., Mukhopadhyay A., McGuire T., et al. HeyL promotes neuronal differentiation of neural progenitor cells. Journal of Neuroscience Research 2011, 89:299-309.
51. Jia H., King I.N., Chopra S.S., Wan H., Ni T.T., Jiang C., et al. Vertebrate heart growth is regulated by functional antagonism between Gridlock and Gata5. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14008-14013.
52. Jin Y., Moller E., Nord K.H., Mandahl N., Von Steyern F.V., Domanski H.A., et al. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes, Chromosomes & Cancer 2012, 51:510-520.
53. Jing W., Xiong Z., Cai X., Huang Y., Li X., Yang X., et al. Effects of gamma-secretase inhibition on the proliferation and vitamin D(3) induced osteogenesis in adipose derived stem cells. Biochemical and Biophysical Research Communications 2010, 392:442-447.
54. Kamakura S., Oishi K., Yoshimatsu T., Nakafuku M., Masuyama N., Gotoh Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nature Cell Biology 2004, 6:547-554.
55. Kang J., Yoo J., Lee S., Tang W., Aguilar B., Ramu S., et al. An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells. Blood 2010, 116:140-150.
56. Kathiriya I.S., King I.N., Murakami M., Nakagawa M., Astle J.M., Gardner K.A., et al. Hairy-related transcription factors inhibit GATA-dependent cardiac gene expression through a signal-responsive mechanism. Journal of Biological Chemistry 2004, 279:54937-54943.
57. King I.N., Kathiriya I.S., Murakami M., Nakagawa M., Gardner K.A., Srivastava D., et al. Hrt and Hes negatively regulate Notch signaling through interactions with RBP-Jkappa. Biochemical and Biophysical Research Communications 2006, 345:446-452.
58. Koibuchi N., Chin M.T. CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression. Circulation Research 2007, 100:850-855.
59. Kokubo H., Lun Y., Johnson R.L. Identification and expression of a novel family of bHLH cDNAs related to Drosophila hairy and enhancer of split. Biochemical and Biophysical Research Communications 1999, 260:459-465.
60. Kokubo H., Miyagawa-Tomita S., Nakashima Y., Kume T., Yoshizumi M., Nakanishi T., et al. Hesr2 knockout mice develop aortic valve disease with advancing age. Arteriosclerosis, Thrombosis, and Vascular Biology 2013, 33:e84-e92.
61. Kokubo H., Miyagawa-Tomita S., Nakazawa M., Saga Y., Johnson R.L. Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Developmental Biology 2005, 278:301-309.
62. Kokubo H., Miyagawa-Tomita S., Tomimatsu H., Nakashima Y., Nakazawa M., Saga Y., et al. Targeted disruption of hesr2 results in atrioventricular valve anomalies that lead to heart dysfunction. Circulation Research 2004, 95:540-547.
63. Kokubo H., Tomita-Miyagawa S., Hamada Y., Saga Y. Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2. Development 2007, 134:747-755.
64. Korrapati S., Roux I., Glowatzki E., Doetzlhofer A. Notch signaling limits supporting cell plasticity in the hair cell-damaged early postnatal murine cochlea. PloS One 2013, 8:e73276.
65. Korten S., Brunssen C., Poitz D.M., Grossklaus S., Brux M., Schnittler H.J., et al. Impact of Hey2 and COUP-TFII on genes involved in arteriovenous differentiation in primary human arterial and venous endothelial cells. Basic Research in Cardiology 2013, 108:362.
66. Larrivee B., Prahst C., Gordon E., del Toro R., Mathivet T., Duarte A., et al. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Developmental Cell 2012, 22:489-500.
67. Lavery K., Hawley S., Swain P., Rooney R., Falb D., Alaoui-Ismaili M.H. New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells. Bone 2009, 45:27-41.
68. Lavery D.N., Villaronga M.A., Walker M.M., Patel A., Belandia B., Bevan C.L. Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors. Journal of Biological Chemistry 2011, 286:17796-17808.
69. Leimeister C., Dale K., Fischer A., Klamt B., Hrabe de Angelis M., Radtke F., et al. Oscillating expression of c-Hey2 in the presomitic mesoderm suggests that the segmentation clock may use combinatorial signaling through multiple interacting bHLH factors. Developmental Biology 2000, 227:91-103.
70. Leimeister C., Externbrink A., Klamt B., Gessler M. Hey genes: A novel subfamily of hairy- and Enhancer of split related genes specifically expressed during mouse embryogenesis. Mechanisms of Development 1999, 85:173-177.
71. Leimeister C., Schumacher N., Steidl C., Gessler M. Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. Mechanisms of Development 2000, 98:175-178.
72. Li H., Cherry S., Klinedinst D., DeLeon V., Redig J., Reshey B., et al. Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population. Circulation. Cardiovascular Genetics 2012, 5:301-308.
73. Li Y., Takeshita K., Liu P.Y., Satoh M., Oyama N., Mukai Y., et al. Smooth muscle Notch1 mediates neointimal formation after vascular injury. Circulation 2009, 119:2686-2692.
74. Li B., Tang S.B., Hu J., Gao Y., Zhang G., Lin S.F., et al. Protective effects of transcription factor HESR1 on retinal vasculature. Microvascular Research 2006, 72:146-152.
75. Liu T., Gao Y., Sakamoto K., Minamizato T., Furukawa K., Tsukazaki T., et al. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines. Journal of Cellular Physiology 2007, 211:728-735.
76. Liu Y., Korte F.S., Moussavi-Harami F., Yu M., Razumova M., Regnier M., et al. Transcription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6. American Journal of Physiology. Heart and Circulatory Physiology 2012, 302:H1860-H1870.
77. Liu Y., Yu M., Wu L., Chin M.T. The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload. American Journal of Physiology. Heart and Circulatory Physiology 2010, 298:H2082-H2092.
78. Lopez-Mateo I., Villaronga M.A., Llanos S., Belandia B. The transcription factor CREBZF is a novel positive regulator of p53. Cell Cycle 2012, 11:3887-3895.
79. Luna-Zurita L., Prados B., Grego-Bessa J., Luxan G., del Monte G., Benguria A., et al. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. Journal of Clinical Investigation 2010, 120:3493-3507.
80. Maier M.M., Gessler M. Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. Biochemical and Biophysical Research Communications 2000, 275:652-660.
81. Mal A., Sturniolo M., Schiltz R.L., Ghosh M.K., Harter M.L. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: Inhibition of the myogenic program. EMBO Journal 2001, 20:1739-1753.
82. Mann C.D., Bastianpillai C., Neal C.P., Masood M.M., Jones D.J., Teichert F., et al. Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma. PloS One 2012, 7:e51119.
83. Monastirioti M., Giagtzoglou N., Koumbanakis K.A., Zacharioudaki E., Deligiannaki M., Wech I., et al. Drosophila Hey is a target of Notch in asymmetric divisions during embryonic and larval neurogenesis. Development (Cambridge, England) 2010, 137:191-201.
84. Moya I.M., Umans L., Maas E., Pereira P.N., Beets K., Francis A., et al. Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. Developmental Cell 2012, 22:501-514.
85. Mukhopadhyay A., Jarrett J., Chlon T., Kessler J.A. HeyL regulates the number of TrkC neurons in dorsal root ganglia. Developmental Biology 2009, 334:142-151.
86. Nakagawa O., McFadden D.G., Nakagawa M., Yanagisawa H., Hu T., Srivastava D., et al. Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:13655-13660.
87. Nakagawa O., Nakagawa M., Richardson J.A., Olson E.N., Srivastava D. HRT1, HRT2, and HRT3: A new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Developmental Biology 1999, 216:72-84.
88. Ozawa Y., Towatari M., Tsuzuki S., Hayakawa F., Maeda T., Miyata Y., et al. Histone deacetylase 3 associates with and represses the transcription factor GATA-2. Blood 2001, 98:2116-2123.
89. Parker B.S., Argani P., Cook B.P., Liangfeng H., Chartrand S.D., Zhang M., et al. Alterations in vascular gene expression in invasive breast carcinoma. Cancer Research 2004, 64:7857-7866.
90. Patel N.S., Li J.L., Generali D., Poulsom R., Cranston D.W., Harris A.L. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Research 2005, 65:8690-8697.
91. Pendeville H., Winandy M., Manfroid I., Nivelles O., Motte P., Pasque V., et al. Zebrafish Sox7 and Sox18 function together to control arterial-venous identity. Developmental Biology 2008, 317:405-416.
92. Pietras A., von Stedingk K., Lindgren D., Pahlman S., Axelson H. JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formation. Molecular Cancer Research 2011, 9:626-636.
93. Popovic M., Wienk H., Coglievina M., Boelens R., Pongor S., Pintar A. The basic-helix-loop-helix region of the transcriptional repressor HES-1 is preorganized to bind DNA. Proteins 2014, 82(4):537-545.
94. Proweller A., Pear W.S., Parmacek M.S. Notch signaling represses myocardin-induced smooth muscle cell differentiation. Journal of Biological Chemistry 2005, 280:8994-9004.
95. Ricard N., Ciais D., Levet S., Subileau M., Mallet C., Zimmers T.A., et al. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 2012, 119:6162-6171.
96. Sakamoto M., Hirata H., Ohtsuka T., Bessho Y., Kageyama R. The basic helix-loop-helix genes Hesr1/Hey1 and Hesr2/Hey2 regulate maintenance of neural precursor cells in the brain. Journal of Biological Chemistry 2003, 278:44808-44815.
97. Sakata Y., Kamei C.N., Nakagami H., Bronson R., Liao J.K., Chin M.T. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:16197-16202.
98. Sakata Y., Koibuchi N., Xiang F., Youngblood J.M., Kamei C.N., Chin M.T. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation. Journal of Molecular and Cellular Cardiology 2006, 40:267-273.
99. Sakata Y., Xiang F., Chen Z., Kiriyama Y., Kamei C.N., Simon D.I., et al. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:2069-2074.
100. Salie R., Kneissel M., Vukevic M., Zamurovic N., Kramer I., Evans G., et al. Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone. Bone 2010, 46:680-694.
101. Sartorelli V., Puri P.L., Hamamori Y., Ogryzko V., Chung G., Nakatani Y., et al. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Molecular Cell 1999, 4:725-734.
102. Satow T., Bae S.K., Inoue T., Inoue C., Miyoshi G., Tomita K., et al. The basic helix-loop-helix gene hesr2 promotes gliogenesis in mouse retina. Journal of Neuroimmune Pharmacology 2001, 21:1265-1273.
103. Scott R.H., Douglas J., Baskcomb L., Huxter N., Barker K., Hanks S., et al. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nature Genetics 2008, 40:1329-1334.
104. Sharff K.A., Song W.X., Luo X., Tang N., Luo J., Chen J., et al. Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. Journal of Biological Chemistry 2009, 284:649-659.
105. Shirvani S.M., Mookanamparambil L., Ramoni M.F., Chin M.T. Transcription factor CHF1/Hey2 regulates the global transcriptional response to platelet-derived growth factor in vascular smooth muscle cells. Physiological Genomics 2007, 30:61-68.
106. Shirvani S., Xiang F., Koibuchi N., Chin M.T. CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6. Biochemical and Biophysical Research Communications 2006, 339:151-156.
107. Sun J., Kamei C.N., Layne M.D., Jain M.K., Liao J.K., Lee M.E., et al. Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. Journal of Biological Chemistry 2001, 276:18591-18596.
108. Takata T., Ishikawa F. Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochemical and Biophysical Research Communications 2003, 301:250-257.
109. Tang Y., Urs S., Liaw L. Hairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site. Circulation Research 2008, 102:661-668.
110. Tateya T., Imayoshi I., Tateya I., Ito J., Kageyama R. Cooperative functions of Hes/Hey genes in auditory hair cell and supporting cell development. Developmental Biology 2011, 352:329-340.
111. Tokuzawa Y., Yagi K., Yamashita Y., Nakachi Y., Nikaido I., Bono H., et al. Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation. PLoS Genetics 2010, 6:e1001019.
112. Tradonsky A., Rubin T., Beck R., Ring B., Seitz R., Mair S. A search for reliable molecular markers of prognosis in prostate cancer: A study of 240 cases. American Journal of Clinical Pathology 2012, 137:918-930.
113. Tu X., Chen J., Lim J., Karner C.M., Lee S.Y., Heisig J., et al. Physiological notch signaling maintains bone homeostasis via RBPjk and Hey upstream of NFATc1. PLoS Genetics 2012, 8:e1002577.
114. van den Berg A., Kroesen B.J., Kooistra K., de Jong D., Briggs J., Blokzijl T., et al. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes, Chromosomes & Cancer 2003, 37:20-28.
115. Van Wayenbergh R., Taelman V., Pichon B., Fischer A., Kricha S., Gessler M., et al. Identification of BOIP, a novel cDNA highly expressed during spermatogenesis that encodes a protein interacting with the orange domain of the hairy-related transcription factor HRT1/Hey1 in Xenopus and mouse. Developmental Dynamics 2003, 228:716-725.
116. Wang L., Motoi T., Khanin R., Olshen A., Mertens F., Bridge J., et al. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes, Chromosomes & Cancer 2012, 51:127-139.
117. Watanabe T., Koibuchi N., Chin M.T. Transcription factor CHF1/Hey2 regulates coronary vascular maturation. Mechanisms of Development 2010, 127:418-427.
118. Watanabe Y., Kokubo H., Miyagawa-Tomita S., Endo M., Igarashi K., Aisaki K., et al. Activation of Notch1 signaling in cardiogenic mesoderm induces abnormal heart morphogenesis in mouse. Development (Cambridge, England) 2006, 133:1625-1634.
119. Wiese C., Heisig J., Gessler M. Hey bHLH factors in cardiovascular development. Pediatric Cardiology 2010, 31:363-370.
120. Williams C.K., Li J.L., Murga M., Harris A.L., Tosato G. Up-regulation of the Notch ligand delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 2006, 107:931-939.
121. Winkler C., Elmasri H., Klamt B., Volff J.N., Gessler M. Characterization of hey bHLH genes in teleost fish. Development Genes and Evolution 2003, 213:541-553.
122. Wu S.P., Cheng C.M., Lanz R.B., Wang T., Respress J.L., Ather S., et al. Atrial identity is determined by a COUP-TFII regulatory network. Developmental Cell 2013, 25:417-426.
123. Xiang F., Sakata Y., Cui L., Youngblood J.M., Nakagami H., Liao J.K., et al. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4. American Journal of Physiology. Heart and Circulatory Physiology 2006, 290:H1997-H2006.
124. Xin M., Small E.M., van Rooij E., Qi X., Richardson J.A., Srivastava D., et al. Essential roles of the bHLH transcription factor Hrt2 in repression of atrial gene expression and maintenance of postnatal cardiac function. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:7975-7980.
125. Yoo J., Lee H.N., Choi I., Choi D., Chung H.K., Kim K.E., et al. Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus. PLoS Pathogens 2012, 8:e1002770.
126. Yu M., Liu Y., Xiang F., Li Y., Cullen D., Liao R., et al. CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways. OMICS 2009, 13:501-511.
127. Yu M., Xiang F., Beyer R.P., Farin F.M., Bammler T.K., Chin M.T. Transcription factor CHF1/Hey2 regulates specific pathways in serum stimulated primary cardiac myocytes: Implications for cardiac hypertrophy. Current Genomics 2010, 11:287-296.
128. Zamurovic N., Cappellen D., Rohner D., Susa M. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. Journal of Biological Chemistry 2004, 279:37704-37715.
129. Zanotti S., Canalis E. Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice. Journal of Biological Chemistry 2013, 288:21547-21557.
130. Zavadil J., Cermak L., Soto-Nieves N., Bottinger E.P. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO Journal 2004, 23:1155-1165.
131. Zhong T.P., Childs S., Leu J.P., Fishman M.C. Gridlock signalling pathway fashions the first embryonic artery. Nature 2001, 414:216-220.
132. Zhong T.P., Rosenberg M., Mohideen M.A., Weinstein B., Fishman M.C. Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science (New York) 2000, 287:1820-1824.